Rigel Pharmaceutical Inc. buy Citigroup Inc.
Start price
06.03.25
/
50%
€0.74
Target price
06.03.26
€50.83
Performance (%)
-
End price
07.03.26
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Rigel Pharmaceutical Inc. | - | - | - |
| iShares Core DAX® | 2,55 % | -0,11 % | 15,00 % |
| iShares Nasdaq 100 | 2,74 % | -0,47 % | 30,95 % |
| iShares Nikkei 225® | 6,58 % | 3,22 % | 49,70 % |
| iShares S&P 500 | 1,93 % | -0,52 % | 24,88 % |
Comments by Citigroup_Inc_ for this prediction
In the thread Rigel Pharmaceutical Inc. diskutieren
Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) had its price target raised by analysts at Citigroup Inc. from $49.00 to $55.00. They now have a "buy" rating on the stock.
Ratings data for RIGL provided by MarketBeat
In the thread Trading Rigel Pharmaceutical Inc.
Die von Citigroup_Inc_ gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Citigroup_Inc_ for Rigel Pharmaceutical Inc.
Rigel Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€0.74
12.11.24
12.11.24
€46.15
12.11.25
12.11.25
-
13.11.25
13.11.25
Rigel Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€1.40
07.03.24
07.03.24
€3.67
07.03.25
07.03.25
-47.24%
08.03.25
08.03.25